Practice 9 structured short- and long-answer medical questions on Endocrine LAqs and SAqs. Review model answers for exam revision.
Answer: .
Answer: Model answer pending
Answer: Model answer pending
Answer: **Adjuvant therapy** – is when hormones are used with other therapies in cancer treatment to reduce side effects. - **Example: **Aromatase inhibitors + Tamoxifen the estrogen receptor antagonist used for treating breast cancer in menopausal women. - The goal of adjuvant therapy for breast cancer is to prevent the recurrence of the disease by eradicating micrometastatic disease. Features of Autacoids
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: **hCG is secreted by trophoblast cells** of the developing placenta shortly after fertilization and implantation. It enters the **maternal bloodstream and urine** within 6–12 days post-conception. The test uses **monoclonal antibodies specific to the β-subunit** of hCG to ensure specificity (avoiding LH cross-reactivity). A **sandwich ELISA or immunochromatographic method** is used to detect hCG levels. A **positive test line** appears when hCG binds to the antibodies, confirming pregnancy. - **Bone Turnover:***Paget’s disease:* Characterized by **increased and disorganized bone remodeling**. - *Osteoporosis:* Involves **decreased bone mass and increased resorption**, with normal remodeling pattern. - **Bone Structure:***Paget’s disease:* Bones become **enlarged, deformed, and structurally weak**. - *Osteoporosis:* Bones are **porous, thinned, and brittle** due to loss of density. - **Biochemical Markers:***Paget’s disease:* Often shows **elevated alkaline phosphatase (ALP)** due to increased osteoblastic activity. - *Osteoporosis:* **Normal ALP**, unless fracture or other condition is present. - **Commonly Affected Sites:***Paget’s disease:* Affects **skull, pelvis, femur, and spine**. - *Osteoporosis:* Common in **vertebrae, hip (femoral neck), and wrist**. **A. Biosynthesis of Catecholamines:** - **Tyrosine** (from phenylalanine) is the precursor. - **Step 1:** Tyrosine → DOPA via *tyrosine hydroxylase*. - **Step 2:** DOPA → Dopamine via *DOPA decarboxylase*. - **Step 3:** Dopamine → Norepinephrine via *dopamine β-hydroxylase*. - **Step 4:** Norepinephrine → Epinephrine via *phenylethanolamine N-methyltransferase* (in adrenal medulla). - Stored in vesicles, released upon stimulation. **B. Role in Human Behavior:** - **Dopamine:** Reward, motivation, mood regulation, addiction, motor control (Parkinson’s, schizophrenia). - **Norepinephrine:** Alertness, attention, arousal, stress response. - **Epinephrine:** Fight-or-flight, enhances fear, anxiety, and performance. - Clinical implications: ADHD, mood disorders, substance abuse. - **GABA-A (ionotropic):** Ligand-gated chloride channels → hyperpolarization → inhibition. Targeted by **benzodiazepines, barbiturates, alcohol**. - **GABA-B (metabotropic):** G-protein coupled → opens K⁺ channels and inhibits Ca²⁺ channels. Affected by **baclofen**. - Both reduce neuronal excitability, contributing to inhibitory neurotransmission. **Importance:** - Produces **cortisol**, **aldosterone**, **androgens** (cortex), and **epinephrine**, **norepinephrine** (medulla). - Regulates stress response, blood pressure, metabolism, and electrolyte balance. **Disorders:** - **Cushing’s Syndrome:** Excess cortisol (hypertension, obesity). - **Addison’s Disease:** Cortisol/aldosterone deficiency (fatigue, hypotension). - **Congenital Adrenal Hyperplasia:** Enzyme defects → androgen excess. - **Pheochromocytoma:** Catecholamine-secreting tumor (sweating, palpitations). **Hypothalamic Hormones:** - **TRH**: Stimulates TSH and prolactin. - **CRH**: Stimulates ACTH. - **GnRH**: Stimulates LH and FSH. - **GHRH**: Stimulates GH. - **Somatostatin**: Inhibits GH and TSH. - **Dopamine**: Inhibits prolactin. **Pituitary Hormones:** - **Anterior Pituitary:****TSH**: Thyroid stimulation. - **ACTH**: Stimulates adrenal cortex. - **GH**: Growth, metabolism. - **PRL**: Lactation. - **FSH/LH**: Reproduction. - **Posterior Pituitary:****ADH**: Water retention. - **Oxytocin**: Uterine contractions, milk ejection. **Clinical Relevance:** - Disorders: Acromegaly, hypopituitarism, SIADH, diabetes insipidus, prolactinoma. - **Inhibits Desire:** High serotonin levels can reduce sexual desire and arousal. - **Sexual Dysfunction:** Low serotonin is linked to issues like premature ejaculation and erectile dysfunction. - **Orgasm Regulation:** Serotonin can delay orgasm and influence sexual response. - **SSRIs:** Antidepressants (SSRIs) affect serotonin, often causing sexual side effects. - **Sensory Neurons:** Transmit sensory information to the CNS (e.g., pain, touch). - **Motor Neurons:** Carry signals from the CNS to muscles/glands (e.g., skeletal muscle). - **Interneurons:** Connect sensory and motor neurons within the CNS, processing information. - **Barbiturates:** Increase GABA’s effect by prolonging chloride channel opening; potent anxiolytic/sedative, but risk of overdose. - **Benzodiazepines:** Increase GABA’s effect by enhancing chloride channel opening frequency; safer than barbiturates, but long-term use can cause dependence. - **Mate Attraction:** Signals reproductive status. - **Territorial Marking:** Marks boundaries. - **Social Communication:** Facilitates group cohesion (e.g., alarm signals). - **Maternal Behavior:** Influences maternal care. - **Uterine Contractions:** Facilitates childbirth. - **Milk Ejection:** Stimulates milk release during breastfeeding. - **Excitatory:** **Glutamate** – Excites neurons. - **Inhibitory:** **GABA** – Inhibits neuronal activity. - **Modulatory:** **Dopamine** – Modulates mood and movement. - **Peptide:** **Endorphins** – Natural pain relief. - **Allelopathic Chemicals:** Inhibit the growth of other organisms. - **Kairomones:** Beneficial to the receiver, e.g., predator locates prey. - **Allomones:** Beneficial to the emitter, e.g., deterrent chemicals. - **Hypothyroidism:** Low hormone levels; symptoms include fatigue and weight gain. - **Hyperthyroidism:** High hormone levels; symptoms include weight loss and tremors. - **Goiter:** Enlarged thyroid, often due to iodine deficiency. - **Thyroid Cancer:** Malignant growth in thyroid cells. - **Thyroid Storm:** Severe hyperthyroidism with life-threatening symptoms. - **Hormone Binding to GPCR:**Hormone binds to the extracellular domain of the GPCR (7-helix receptor). - Conformational change in the receptor activates the G-protein on the cytosolic side. - **GDP-GTP Exchange:**The nucleotide-binding site on **Ga** becomes accessible to GTP. - **Ga** releases GDP and binds GTP, activating the G-protein. - **Dissociation of Ga-GTP:****Ga-GTP** dissociates from the inhibitory **bγ** complex. - **Ga-GTP** can now bind to and activate **Adenylyl Cyclase (AC)**. - **Activation of Adenylyl Cyclase:****Adenylyl Cyclase** is activated by **Ga-GTP**, catalyzing the synthesis of **cAMP** from ATP. - **Activation of Protein Kinase A (PKA):****cAMP** activates **Protein Kinase A (PKA)**. - **PKA** transfers phosphate from ATP to cellular proteins, altering their activity. - **GTP Hydrolysis by Ga (GTPase Activity):****Ga** hydrolyzes **GTP** to **GDP** and **Pi**. - This causes **Ga** to rebind to the **bγ** complex, turning off the signal. - **Adenylyl Cyclase** is no longer activated. - **Hydrolysis of cAMP (Phosphodiesterases):****Phosphodiesterases** hydrolyze **cAMP** into **AMP**, reducing signal strength. - **Receptor Desensitization:**Activated receptors may be phosphorylated by **G-protein Receptor Kinase** (GRK). - Phosphorylated receptors may bind **β-arrestin**, which promotes receptor removal or internalization. - **β-arrestin** can also recruit **phosphodiesterase**, bringing it closer to cAMP production to enhance signal turnoff. - **Dephosphorylation of Proteins (Protein Phosphatase):****Protein Phosphatase** removes phosphates from proteins previously phosphorylated by **PKA**, reversing the cellular effects. - **Toxin Production:**Both **Cholera toxin** and **Pertussis toxin** involve the process of **ADP-ribosylation**. - **Cholera Toxin Mechanism:****Cholera toxin** catalyzes **ADP-ribosylation** of **Gαs** (stimulatory G-protein). - ADP-ribose is transferred from **NAD+** to an **arginine** residue at the GTPase active site of **Gαs**. - This prevents **GTP hydrolysis** by **Gαs**, leading to its **permanent activation**. - Results in overstimulation of **adenylyl cyclase**, causing excessive **cAMP** production, leading to symptoms. - **Pertussis Toxin Mechanism:****Pertussis toxin** catalyzes **ADP-ribosylation** at a **cysteine residue** of the **Gαi** (inhibitory G-protein). - **Gαi** becomes unable to exchange **GDP** for **GTP**. - This blocks the **inhibitory pathway** of **Gαi**, preventing the negative regulation of **adenylyl cyclase**, leading to an increase in **cAMP**. - **General Mechanism of ADP-Ribosylation:**ADP-ribosylation regulates protein activity in both **eukaryotes** (including mammals) and **prokaryotes**. - Both toxins exploit this mechanism to disrupt normal cellular signaling. - **Gastrin** – Stimulates gastric acid secretion. - **Secretin** – Stimulates bicarbonate release from pancreas. - **Cholecystokinin (CCK)** – Stimulates gallbladder contraction and pancreatic enzyme release. - **Ghrelin** – Stimulates hunger. - **Motilin** – Regulates gastrointestinal motility. - **Gastric Inhibitory Peptide (GIP)** – Inhibits gastric secretion, stimulates insulin release. - **Glucocorticoids** – e.g., Cortisol. - **Mineralocorticoids** – e.g., Aldosterone. - **Androgens** – e.g., Testosterone. - **Estrogens** – e.g., Estradiol. - **Progestogens** – e.g., Progesterone. - **Vitamin D derivatives** – e.g., Calcitriol - **Osteoporosis****Features**: Decreased bone mass, increased bone resorption, fragile bones - **Treatment**: **Bisphosphonates**, **estrogen therapy** - **Paget’s Disease of Bone****Features**: Excessive, disorganized bone turnover; bone pain and deformities - **Treatment**: **Bisphosphonates**, **calcitonin** --- --- - **Hypothyroidism**: Low thyroid hormone levels. Symptoms: Fatigue, weight gain.**Treatment**: Levothyroxine. - **Hyperthyroidism**: Excess thyroid hormone. Symptoms: Weight loss, rapid heart rate.**Treatment**: Methimazole, radioactive iodine. - **Goiter**: Enlarged thyroid.**Treatment**: Iodine supplementation, surgery. - **Hashimoto's Thyroiditis**: Autoimmune hypothyroidism.**Treatment**: Levothyroxine. - **Thyroid Cancer**: Malignant thyroid growth.**Treatment**: Surgery, radioactive iodine. **Eicosanoids** are lipid mediators derived from arachidonic acid and include prostaglandins, leukotrienes, and thromboxanes. They act locally in the tissues where they are produced, exhibiting hormone-like effects. - **Prostaglandins****Action**: Inflammation, vasodilation, and pain mediation. - **Example**: Prostaglandin E2 (PGE2) promotes inflammation in response to infection or injury. - **Leukotrienes****Action**: Involved in immune responses, especially in allergic reactions and asthma. - **Example**: Leukotriene B4 (LTB4) attracts neutrophils to infection sites, aiding in inflammation. - **Thromboxanes****Action**: Promote platelet aggregation and vasoconstriction, aiding in blood clotting. - **Example**: Thromboxane A2 (TXA2) induces platelet aggregation and vasoconstriction during blood clot formation. Eicosanoids play significant hormone-like roles in regulating inflammation, immune response, and vascular function, and their effects are localized to the tissues where they are synthesized. **Adjuvant Therapy** refers to additional treatment given after the primary treatment to enhance its effectiveness, especially in cancer or hormone-related disorders. - **Example**: *Tamoxifen* is an adjuvant therapy used after surgery in estrogen receptor-positive breast cancer. - **Mechanism**: Tamoxifen blocks estrogen receptors, reducing the risk of cancer recurrence. - **Purpose**: In adjuvant therapy, the hormone or drug enhances the effect of the primary treatment, such as surgery or chemotherapy. ### **Ion Channel Receptors ** - **Structure**: Receptor protein is part of an ion channel complex. - **Activation**: Messenger binding causes an induced fit. - **Ion Channel Opening**: Channel opens/closes, allowing specific ions (Na⁺, Ca²⁺, Cl⁻, K⁺) to flow. - **Ion Flow**: Ions move down their concentration gradient. - **Cell Response**: Alters cell polarization (depolarization or hyperpolarization). - **Effect**: Modifies enzyme activity within the cell. - **Gating Mechanism**: Messenger binding triggers pore opening. - **Speed**: Fast response (milliseconds), ideal for nerve transmission. - **Thyroid Hormones**: TSH, T3, T4 levels diagnose hypo/hyperthyroidism. - **Corticosteroids**: Cortisol levels diagnose Addison’s or Cushing’s disease. - **Insulin/Glucose**: Measures diabetes and insulin resistance. - **Sex Hormones**: Estrogen, testosterone for reproductive disorders (e.g., PCOS). - **Growth Hormones**: GH and IGF-1 levels diagnose pituitary dysfunction. - **Metabotropic receptors**: G-protein-coupled receptors (GPCRs); act indirectly via second messengers. - **Ionotropic receptors**: Ligand-gated ion channels; directly mediate ion flow across membranes. - **Adrenaline (epinephrine)** - **Noradrenaline (norepinephrine)** - **Paracrine hormones** act on nearby target cells by diffusing through the interstitial fluid. - **Other hormone types**:**Endocrine**: Travel via blood to distant targets. - **Autocrine**: Act on the same cell that secreted them. - **Juxtacrine**: Require direct cell-to-cell contact. - They release **progestin** locally in the uterus. - Thicken cervical mucus, inhibit sperm penetration. - Suppress endometrial growth to prevent implantation. - **Estrogens**: Estradiol, estrone, estriol - **Androgens**: Testosterone, dihydrotestosterone (DHT), androstenedione - **Metabotropic receptors**: G-protein-coupled receptors that activate intracellular signaling cascades (e.g., GPCRs). - **Ionotropic receptors**: Ligand-gated ion channels that open to allow ion flow upon neurotransmitter binding. - Epinephrine (Adrenaline) - Norepinephrine (Noradrenaline) - **Paracrine hormones** act **locally** on **nearby target cells** without entering systemic circulation. - They diffuse short distances to bind receptors and alter cell activity (e.g., somatostatin in the pancreas). - *Compare:***Endocrine hormones**: travel via blood to distant organs (e.g., insulin). - **Autocrine hormones**: act on the same cell that secretes them (e.g., IL-2 in T cells). - **Juxtacrine signals**: require direct cell-to-cell contact. - Devices (e.g., **LNG-IUS**) inserted into the uterus that **release progestin**. - They **thicken cervical mucus**, **inhibit ovulation**, and **alter endometrium** to prevent implantation. - Example: **Mirena® (levonorgestrel intrauterine system)**. - **Estrogens**:Estradiol (E2) – main reproductive estrogen - Estrone (E1) – postmenopausal estrogen - Estriol (E3) – produced in pregnancy - **Androgens**:Testosterone - Dihydrotestosterone (DHT) - Dehydroepiandrosterone (DHEA) #### **Biosynthesis of Catecholamines**: - **Phenylalanine → Tyrosine***(via phenylalanine hydroxylase)* - **Tyrosine → L-DOPA***(via tyrosine hydroxylase — rate-limiting step)* - **L-DOPA → Dopamine***(via DOPA decarboxylase)* - **Dopamine → Norepinephrine***(via dopamine β-hydroxylase)* - **Norepinephrine → Epinephrine***(via phenylethanolamine-N-methyltransferase in adrenal medulla)* #### **Roles in Neurotransmission & Human Behavior**: - **Dopamine**:Reward and pleasure - Motivation and learning - Linked to schizophrenia & Parkinson’s disease - **Norepinephrine**:Arousal, alertness - Fight-or-flight response - Dysregulation: linked to depression and anxiety - **Epinephrine**:Reinforces norepinephrine effects peripherally - Increases cardiac output and glucose release - Minor CNS neurotransmitter #### **GABA Receptor Types**: - **GABA-A receptors****Ionotropic (ligand-gated Cl⁻ channels)** - Fast inhibitory neurotransmission - Activated by: GABA, benzodiazepines, barbiturates, alcohol - Inhibition causes sedation, anxiolysis, anesthesia - **GABA-B receptors****Metabotropic (GPCRs)** - Linked to K⁺ channel opening and Ca²⁺ inhibition - Slower, prolonged inhibition - Activated by: baclofen (muscle relaxant) #### **Pharmacological Effects**: - **Anticonvulsants**: enhance GABA activity (e.g., diazepam) - **Anxiolytics**: reduce anxiety via GABA-A (e.g., alprazolam) - **Sedatives**: induce sleep and calmness #### **Importance**: - Produces **cortisol, aldosterone, and catecholamines** - Regulates **stress, metabolism, BP, immune response** #### **Disorders**: - **Addison’s disease** – adrenal insufficiency, ↓ cortisol - **Cushing’s syndrome** – excess cortisol - **Pheochromocytoma** – adrenal medulla tumor, ↑ catecholamines - **Congenital adrenal hyperplasia (CAH)** – enzyme defects, hormone imbalance #### **Hypothalamic Hormones**: - **Releasing hormones**:TRH – stimulates TSH & prolactin - GnRH – stimulates LH & FSH - CRH – stimulates ACTH - GHRH – stimulates GH - **Inhibitory hormones**:Somatostatin – inhibits GH & TSH - Dopamine – inhibits prolactin #### **Pituitary Hormones**: - **Anterior Pituitary (Adenohypophysis)**:GH – growth & metabolism - TSH – stimulates thyroid hormones - ACTH – stimulates adrenal cortex - LH – stimulates sex hormone production - FSH – stimulates gamete production - Prolactin – milk production - **Posterior Pituitary (Neurohypophysis)**:ADH – water reabsorption in kidneys - Oxytocin – uterine contraction & milk let-down